21 C.F.R. § 516.498

Crofelemer.

Last amended: 2023Year: 2026Length: 117 wordsSubsections: 3Official source

Cite as 21 C.F.R. § 516.498 (2026)

(a) Specifications. Each delayed-release tablet contains 125 milligrams (mg) crofelemer. (b) Sponsor. See No. 086149 in § 510.600(c) of this chapter. (c) Conditions of use —(1) Amount. Administer 1 tablet orally twice daily for 3 days for dogs weighing ≤140 pounds. Administer 2 tablets orally twice daily for 3 days for dogs weighing >140 pounds. (2) Indications for use. For the treatment of chemotherapy-induced diarrhea in dogs. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal law to use this product other than as directed in the labeling. [87 FR 17944, Mar. 29, 2022. Redesignated at 88 FR 16546, Mar. 20, 2023]
Cross-references to the CFR
510.600
21 C.F.R. § 516.498: Crofelemer. | Justis AI